Safety and efficacy of transjugular intrahepatic portosystemic shunt combined with palliative treatment in patients with hepatocellular carcinoma

Table 7 Causes of death in the two groups

Classification of death	Group A	Group B	P value
VB	7 (7/212, 3.30%)	42 (42/136, 30.88%)	0.006
Hepatic tumor	56 (56/212, 26.41%)	29 (29/136, 21.32%)	0.173
Hepatic failure	25 (25/212, 11.79%)	23 (23/136, 16.91%)	0.246
Multiorgan failure	24 (24/212, 11.32%)	17 (17/136, 12.50%)	0.257
Others	12	3	/

The mortality rate for VB in Group A was lower than in Group B (P = 0.006), but the rates of hepatic tumor, hepatic failure, and multiorgan failure did not differ significantly between the two groups (P = 0.173, 0.246, 0.257, respectively). VB: Variceal bleeding.